Bridgewater Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
Bridgewater Associates's MDRX Position: Q4 2023 in Review
Bridgewater Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2023, closing a stake of 137,907 shares — an estimated $1.81M sold.
Bridgewater Associates first reported a position in MDRX in Q4 2022 and held it in 4 quarters. The position peaked at $1.81M in Q3 2023. 225 funds tracked by Wall St. Rank hold MDRX as of Q4 2023.
- Bridgewater Associates reported no remaining Veradigm Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Bridgewater Associates sold 137,907 Veradigm Inc. Common Stock shares in Q4 2023, an estimated $1.81M.
- Bridgewater Associates first reported a position in Veradigm Inc. Common Stock in Q4 2022 and held it in 4 quarters.
- Bridgewater Associates's Veradigm Inc. Common Stock position peaked at $1.81M in Q3 2023.
- 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2023.
Based on Bridgewater Associates's 13F filing for Q4 2023, filed 14 Feb 2024.